Table 5.
Knowledge of injectable contraceptives retention from posttest to 9 months among CPs and Tier 2 PPMVs (n = 485)
| Posttest (n = 485) | 9 months later, among those that answered correctly at posttest | |
|---|---|---|
| Syringe and needle are used to administer Depo-Provera | (n = 420) | |
| Incorrect | 12.2 | 7.9 |
| Correct | 86.6 | 92.1 |
| Depo-Provera is administered intramuscularly | (n = 451) | |
| Incorrect | 7.0 | 15.7 |
| Correct | 93.0 | 84.3 |
| Depo-Provera can be administered in buttocks, deltoid, thighs | (n = 385) | |
| Incorrect | 20.6 | 19.5 |
| Correct | 79.4 | 80.5 |
| Depo-Provera is administered every 3 months | (n = 460) | |
| Incorrect | 5.2 | 3.5 |
| Correct | 94.8 | 96.5 |
| Uniject is used to administer Sayana Press | (n = 429) | |
| Incorrect | 8.7 | 4.9 |
| Correct | 88.5 | 95.1 |
| Sayana Press is administered subcutaneously | (n = 441) | |
| Incorrect | 9.1 | 9.3 |
| Correct | 90.9 | 90.7 |
| Sayana Press can be administered on thighs, abdominal wall, back of the arm | (n = 260) | |
| Incorrect | 44.7 | 48.1 |
| Correct | 53.6 | 51.9 |
| Sayana Press is administered every 3 months | (n = 416) | |
| Incorrect | 14.2 | 9.6 |
| Correct | 85.8 | 90.4 |
| Depo Provera/Sayana Press have same active drug | (n = 429) | |
| Incorrect | 11.5 | 4.2 |
| Correct | 88.5 | 95.8 |
| Sharp box contents disposed at health facility | (n = 205) | |
| Incorrect | 57.7 | 17.6 |
| Correct | 42.3 | 82.4 |
| Injectables stored at room temperature and out of direct sunlight | (n = 448) | |
| Incorrect | 4.7 | 7.1 |
| Correct | 92.4 | 92.9 |